Photo by Anna May Photography Stephanie Virgin was 29 and hoping to start a family, so ovarian cancer was the last thing on her mind — even when she experienced…
The lump on Lonnie Gardner’s left arm looked innocuous. Maybe an insect bite, he reasoned. For weeks in 2014, the human resources professional went about his business, unconcerned. But the…
I have gone through it — you know, the losing of my hair, losing my fingernails, my toenails, my breasts. I was diagnosed with stage 4 breast cancer on July…
A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm…
David Elder considers himself lucky. Had things gone differently, the 66-year-old retired accounting professional might have become another lung cancer death statistic. In 2017, David developed what he thought was…
Louisville researchers are turning their success with immunotherapy toward a new foe — the deadly glioblastoma brain cancer. Renato V. LaRocca, M.D., a neuro-oncologist and cancer medicine specialist with Norton…
Adam D. Lye, M.D., is a proud Kentuckian. The medical oncologist/hematologist grew up in Covington and attended medical school at the University of Kentucky College of Medicine in Lexington. For…
As a cancer specialist and neuro-oncologist at Norton Cancer Institute, Renato V. LaRocca, M.D., diagnoses and treats high-grade brain tumors and other solid tumors. Last summer, he applied the same…
The U.S. Food and Drug Administration recently approved a new cancer drug that has been available only to patients enrolled by a Norton Cancer Institute physician and one other researcher…